Our results suggest that folate metabolism- and glutamine metabolism-related genes, especially SLC1A5 and MTHFD2, are associated with KIRC prognosis, tumor stage, and lymph node metastasis status. This evidence concerns the gene SLC1A5 and neoplasm.